Sort
15,842 grants matching “pancreatic cancer”
Motion Management of Pancreatic Cancer in MRI-Guided Radiotherapy
$336,723Ke Sheng · University Of California Los Angeles · R01 · FY2018 · CA
Hedgehog Pathway Blockade by Small-Molecule Gli Antagonists
$336,619James K Chen · Stanford University · R01 · FY2010 · CA
The Paradoxical Role of mTORC1 in the Growth of Nutrient-deprived Pancreatic Cancer Cells Harboring Ras Mutations
$336,616Craig B Thompson · Sloan-Kettering Inst Can Research · R01 · FY2019 · CA
Flavoproteins in Oxidative Protein Folding
$336,600Colin Thorpe · University Of Delaware · R01 · FY2012 · GM
Mechanisms Underlying Replication Stress And Genome Instability Upon BRCA2 Deficiency
$336,543Shailja Pathania · University Of Massachusetts Boston · R01 · FY2024 · CA
Polymeric Nanomedicines of Small Molecules and miRNA for Treating Pancreatic Canc
$336,360Ram I Mahato · University Of Nebraska Medical Center · R01 · FY2015 · EB
T32: Predoctoral and Postdoctoral Training Program in Nanotechnology for Cancer Research
$336,311Denis Wirtz · Johns Hopkins University · T32 · FY2018 · CA
Tumor Antigens for Individual Signatures and Therapy
$336,291Elizabeth Marion Jaffee · Johns Hopkins University · P50 · FY2014 · CA
Project 1: Overcoming Tumor-Induced Immune Suppression to Improve Responses to Immunotherapy
$336,191David G Denardo · Washington University · P50 · FY2020 · CA
A novel molecular cross-talk driving pancreatic cancer progression
$336,158Ajay Pratap Singh · University Of South Alabama · R01 · FY2019 · CA
(PQB6) Genetics of Subclonal Evolution in Pancreatic Cancer
$336,150Christine A Iacobuzio-Donahue · Johns Hopkins University · R01 · FY2013 · CA
Annexin A2 as a mediator of pancreatic cancer metastases
$336,150Lei Zheng · Johns Hopkins University · R01 · FY2013 · CA
Annexin A2 as a mediator of pancreatic cancer metastases
$336,150Lei Zheng · Johns Hopkins University · R01 · FY2016 · CA
Annexin A2 as a mediator of pancreatic cancer metastases
$336,150Lei Zheng · Johns Hopkins University · R01 · FY2015 · CA
Annexin A2 as a mediator of pancreatic cancer metastases
$336,150Lei Zheng · Johns Hopkins University · R01 · FY2017 · CA
Interactions of the angiopoietin and PD-ECGF pathways in tumor angiogenesis
$336,129Edward L Schwartz · Albert Einstein College Of Medicine · R01 · FY2014 · CA
VALIDATING AND TARGETING LYSOPHOSPHATIDIC ACID ACYLTRANSFERASE-BETA IN CANCER
$336,129Gregory Springett · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2011 · CA
Hedgehog Pathway Blockade by Small-Molecule Gli Antagonists
$336,123James K Chen · Stanford University · R01 · FY2009 · CA
Project 2 - Fatty Liver Predisposes to Metastasis: Role of Hepatic Stellate Cells
$336,117Ekihiro Seki · Cedars-Sinai Medical Center · P01 · FY2021 · CA
Mechanisms of MEK/ERK growth arrest signaling
$336,105Jong-In Park · Medical College Of Wisconsin · R01 · FY2019 · CA
Evaluation of CYP24 as a Target for Enhancing Vitamin D*
$336,100Donald L Trump · Roswell Park Cancer Institute Corp · R21 · FY2006 · CA
Biomarker screening algorithms for the improved early detection of hepatocellular carcinoma
$336,024Nabihah Tayob · University Of Tx Md Anderson Can Ctr · R01 · FY2019 · CA
A novel therapy for pancreatic neuroendocrine tumors
$336,000Asfar S Azmi · Wayne State University · R01 · FY2024 · CA
Targeting Akt/NF-kappa beta for Pancreatic Cancer Therapy
$335,975Wayne State University · R01 · FY2005 · CA
Cancer Biology Training Program
$335,830Jennifer D Black · University Of Nebraska Medical Center · T32 · FY2012 · CA